“Disconnection as a Mechanism for Cognitive Dysfunction in Multiple Sclerosis.” Dineen RA, Vilisaar J, Hlinka J, Bradshaw CM, Morgan PS, Constantinescu CS, Auer DP. Brain, 132:239-249 (2008).
“Structural and Metabolic Brain Abnormalities in Preclinical Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leucoencephalopathy.” Stromillo ML, Dotti MT, Battaglini M, Mortilla M, Bianchi S, Plewnia K, Pantoni L, Inzitari D, Federico A, De Stefano N. J Neurol Neurosurg Psychiatry, 80:41-47 (2009).
“Plasma Levels of Asymmetric Dimethylarginine in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarct and Leukoencephalopathy.” Rufa A, Blardi P, De Lalla A, Cevenini G, De Stefano N, Zicari E, Auteri A, Federico A, Dotti MT. Cerebrovasc Dis, 26:636-640 (2008).
“Genomic Effects of Once-Weekly, Intramuscular Interferon-Β1a Treatment After the First Dose and on Chronic Dosing: Relationships to 5-year Clinical Outcomes in Multiple Sclerosis Patients.” Weinstock-Guttman B, Bhasi K, Badgett D, Tamano-Blanco M, Minhas M, Feichter J, Patrick K, Munschauer F, Bakshi R, Ramanathan M. Journal of Neuroimmunology, 205:113-125 (2008).
“Cognitive Assessment and Quantitative Magnetic Resonance Metrics Can Help to Identify Benign Multiple Sclerosis.” Amato MP, Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, De Stefano N. Neurology, 71:632-638 (2008).
“Carotid Intraplaque Hemorrhage Detected by Magnetic Resonance Imaging Predicts Embolization During Carotid Endarterectomy.” Altaf N, Beech A, Goode SD, Gladman JR, Moody AR, Auer DP, MacSweeney ST. J Vasc Surg, 47:337-342 (2008).
“Effect of Laquinimod on MRI-monitored Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis: a Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IIb Study.” Comi G, Pulizzi A, Rovaris M, Abramsky O, Arbizu T, Boiko A, Gold R, Havrdova E, Komoly S, Selmaj K, Sharrack B, Filippi M; LAQ/5062 Study Group. Lancet, 371:2085-2092 (2008).
“BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy.” Hilberg F, Roth GJ, Krssak M, Kautschitsch S, Sommergruber W, Tontsch-Grunt U, Garin-Chesa P, Bader G, Zoephel A, Quant J, Heckel A, Rettig WJ. Cancer Res, 15:4774-4782 (2008).
“Perfusion Magnetic Resonance Imaging Correlates of Neuropsychological Impairment in Multiple Sclerosis.” Inglese M, Adhya S, Johnson G, Babb JS, Miles L, Jaggi H, Herbert J, Grossman RI. J Cereb Blood Flow Metab, 28:164-171 (2008).